On December 11th, CARSGEN-B (02171) spent approximately 15.88 million Hong Kong dollars to repurchase 1.02 million shares.
KPC Pharmaceuticals-B (02171) announced that on December 11, 2025, it will spend approximately 15.88 million Hong Kong dollars to repurchase 1.02 million shares.
CARSGEN-B (02171) announced that it plans to repurchase 1.02 million shares at a cost of approximately 15.8862 million Hong Kong dollars on December 11, 2025.
Related Articles
"The 'Sky-high Monkey' Returns to CRO, will the 20cm Big Red Pillar sound the charge for Joinn Laboratories (06127) stock price to rebound?"
Sinolink: Policy + Technology + Performance Triple Inflection Point. Commercial Aerospace meets Singularity Moment.
New stock news | Oudong New Energy submitted an application to the Hong Kong Stock Exchange, becoming China's largest independent third-party electric exchange solution provider.
"The 'Sky-high Monkey' Returns to CRO, will the 20cm Big Red Pillar sound the charge for Joinn Laboratories (06127) stock price to rebound?"
Sinolink: Policy + Technology + Performance Triple Inflection Point. Commercial Aerospace meets Singularity Moment.
New stock news | Oudong New Energy submitted an application to the Hong Kong Stock Exchange, becoming China's largest independent third-party electric exchange solution provider.
RECOMMEND
Valued At $10 Trillion, The Largest IPO In History Is Coming As SpaceX Announces Listing Plan
12/12/2025
Five Imperatives And Eight Tasks: Central Meeting Specifies Next Year’s Economic Work, Highlights Identified
12/12/2025
Over 100 New Listings In Hong Kong This Year As Total Fundraising Tops HKD 270 Billion, Eighteen “A+H” Dual Listings
12/12/2025
